139 related articles for article (PubMed ID: 1980891)
1. The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment.
Peacock L; Lublin H; Gerlach J
Eur J Pharmacol; 1990 Sep; 186(1):49-59. PubMed ID: 1980891
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
Lublin H; Gerlach J; Peacock L
Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
[TBL] [Abstract][Full Text] [Related]
3. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
Lublin H; Gerlach J; Peacock L
Clin Neuropharmacol; 1992 Dec; 15(6):448-58. PubMed ID: 1362136
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
Lublin H; Gerlach J; Mørkeberg F
Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
[TBL] [Abstract][Full Text] [Related]
5. Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.
Kistrup K; Gerlach J
Pharmacol Toxicol; 1987 Sep; 61(3):157-61. PubMed ID: 2891133
[TBL] [Abstract][Full Text] [Related]
6. Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Peacock L; Gerlach J
Eur J Pharmacol; 1993 Jun; 237(2-3):329-40. PubMed ID: 8103465
[TBL] [Abstract][Full Text] [Related]
7. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
Peacock L; Hansen L; Mørkeberg F; Gerlach J
Neuropsychopharmacology; 1999 Jan; 20(1):35-43. PubMed ID: 9885783
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor agonist- and antagonist-induced behaviors in primates previously treated with dopamine receptor antagonists: the pathogenetic mechanisms of acute oral dyskinesia.
Lublin H
Clin Neuropharmacol; 1995 Dec; 18(6):533-51. PubMed ID: 8681313
[TBL] [Abstract][Full Text] [Related]
9. Effect of selective D1 and D2 dopamine receptor antagonists and agonists in Cebus monkeys: implications for acute and tardive dyskinesias. A preliminary report.
Gerlach J; Kistrup K; Korsgaard S
Psychopharmacol Ser; 1987; 3():236-42. PubMed ID: 3547396
[No Abstract] [Full Text] [Related]
10. Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol.
Lublin H; Gerlach J
Eur J Pharmacol; 1988 Aug; 153(2-3):239-45. PubMed ID: 3263277
[TBL] [Abstract][Full Text] [Related]
11. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
12. Mediation of rat postejaculatory 22 kHz ultrasonic vocalization by dopamine D2 receptors.
Cagiano R; Barfield RJ; White NR; Pleim ET; Cuomo V
Pharmacol Biochem Behav; 1989 Sep; 34(1):53-8. PubMed ID: 2576313
[TBL] [Abstract][Full Text] [Related]
13. Effect of D1 receptor stimulation in normal and MPTP monkeys.
Bédard PJ; Boucher R
Neurosci Lett; 1989 Sep; 104(1-2):223-8. PubMed ID: 2573015
[TBL] [Abstract][Full Text] [Related]
14. Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions.
Peacock L; Gerlach J
Biol Psychiatry; 2001 Oct; 50(7):501-9. PubMed ID: 11600103
[TBL] [Abstract][Full Text] [Related]
15. Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.
Furmidge LJ; Exner M; Clark D
Eur J Pharmacol; 1991 Sep; 202(2):191-9. PubMed ID: 1687032
[TBL] [Abstract][Full Text] [Related]
16. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
Double KL; Crocker AD
Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
Andersen PH
Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
[TBL] [Abstract][Full Text] [Related]
18. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.
Coffin VL; Latranyi MB; Chipkin RE
J Pharmacol Exp Ther; 1989 Jun; 249(3):769-74. PubMed ID: 2567351
[TBL] [Abstract][Full Text] [Related]
19. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
20. The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat.
Nakajima S; O'Regan NB
Pharmacol Biochem Behav; 1991 Jun; 39(2):465-8. PubMed ID: 1682950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
